Jakko van Ingen received the ESCMID Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease.During the European Conference on Clinical Microbiology and Infectious Diseases (ECCMID), consultant clinical microbiologist and RIHS scientist Jakko van Ingen received the Young Investigator Award for his groundbreaking work on nontuberculous mycobacterial disease. Jakko has performed landmark studies which showed that pathogenicity of nontuberculous mycobacteria differs strongly by species, that current antibiotic treatment regimens can be optimized by better use of susceptibility testing and that several new and repurposed antibiotics can improve treatment outcomes in nontuberculous mycobacterial disease. For this work, captured in 170 papers in peer-reviewed journals and 10 book chapters, he received this prestigious award.
Jakko van Ingen is member of theme Infectious diseases and global health.
Related news items
Guiding the surgeon real-time tumor visualization during surgery26 February 2020
Incomplete excision of tumor tissue, negatively affects the prognosis of the patient. Mark Rijpkema and colleagues are working on the development of new dual-labeled tracers and currently are implementing this into the clinic.read more
Jurgen Fütterer appointed Professor of Image-Guided Oncological Interventions26 February 2020
Fütterer is an interventional radiologist and is also Professor at the Robotics and Mechatronics Group at the University of Twente. The new professor is an expert in the field of cancer imaging techniques, image-guided interventions and robotics.read more
Arnt Schellekens appointed Professor of Addicition and Psychiatry26 February 2020
Arnt Schellekens has been appointed professor of Addiction and Psychiatry at Radboud University / Radboud university medical center with effect from 1 January 2020.read more
NWO GROOT grant for Michiel Vermeulen24 February 2020
Michiel Vermeulen, theme Cancer development and immune defense, received a 300,000 EUR grant within the NWO-GROOT consortium. He will use mass spectrometry-based proteomics and interaction proteomics applications to study proteome and gene expression dynamics during early C. Elegans development.read more